10th January 2023
9th September 2022
Photys Therapeutics Debuts with $75 Million Series A Funding to Advance New Class of Bifunctional Molecules for Precision Phosphorylation to Modulate and Repair Disease-Driving Proteins
31st August 2022
Umoja’s Unified Approach to Exceeding the Limitations of Cell Therapy
25th August 2022
Aktis Oncology Raises $84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals
18th August 2022
Orna goes into orbit on $3.65B Merck megadeal, $221M series B round
16th August 2022
Orna Therapeutics: circular logic
16th August 2022
BioImpact Capital, an MPM affiliate, Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer
16th August 2022
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
16th August 2022
Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic
2nd June 2022